Purchase Order 75N95023P00778

Award Date 9/8/23
Potential Completion Date 9/7/24
Potential Value $25K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
University of Maryland, Baltimore has been awarded a $24,905.51 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to provide testing services for sign and goal tracking. The contract has no set-aside designation and work is to be completed by April 12, 2024 at the place of performance in Baltimore, Maryland. As an academic institution and medical center, University of Maryland, Baltimore will leverage its expertise in biomedical research...
The University of Maryland, Baltimore (UMB) was awarded a $732,602 firm-fixed-price contract from the National Institutes of Health (NIH) Clinical Center to conduct two clinical research studies evaluating novel treatments for methamphetamine and cocaine use disorders in the Baltimore/Washington, D.C. region. This contract, which runs from September 2024 through September 2027, supports NIH's priorities related to reducing the incidence of HIV and associated comorbidities. UMB, a major public...
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a firm fixed price purchase order valued at one hundred ninety-seven thousand five hundred eleven dollars and sixty-two cents ($197,511.62) to the University of Maryland, Baltimore for work related to "SENSING: MAPPING GENE EXPRESSION NETWORKS THAT DISTINGUISH OPIOID USE DISORDER FROM CHRONIC PAIN." The University of Maryland, Baltimore will perform the...
This $522,500.00 firm fixed price purchase order was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences to the University of Maryland, College Park, a state-controlled institution of higher learning, to provide CIT/network services to support the state of Maryland. The contract has no set-aside designation. The University of Maryland, College Park is the prime contractor under this contract and is a...
This federal contract award is for UNIVERSITY OF MARYLAND TUITION AND EDUCATION FEES, provided by the University of Maryland, College Park to the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is a firm fixed price purchase order with a potential value of $10,320.50, and has a completion date of January 27, 2020. The contract does not have a set-aside designation. The University of Maryland, College...
This contract award is a RATIFICATION OF UNAUTHORIZED COMMITMENT made by the National Institute of Dental and Craniofacial Research (NIDCR), part of the Department of Health and Human Services National Institutes of Health, to the University of Maryland, College Park (UMDCP) for a PREDOCTORAL FELLOW. The $5,848 firm fixed price purchase order does not have a set-aside designation. UMDCP, a state-controlled institution of higher learning, has a history of providing research, engineering, and...
The University of Maryland, Baltimore was awarded a $7,564 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide custom sequencing reactions in support of the agency's biomedical research efforts. As the prime contractor, the University of Maryland will leverage its expertise in genomic sequencing and analysis to deliver the requested products and services over a five year period from 2010 through 2015. No...
This is a $11,109,751.80 Firm Fixed Price contract awarded by the National Institutes of Health (NIH) to the University of Maryland, Baltimore (UMB) to provide support for the Office of AIDS Research Initiative research grant activities. The contract has a period of performance through September 27, 2027 and was awarded on September 28, 2022. UMB, a prominent public research university, will be the prime contractor delivering these services without any set-aside designation. The University...
This is a purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to the University of Maryland, College Park. The $4,308.43 firm fixed price contract is for spring 2015 tuition courses for student Seong-In Hyun. The contract does not have a set-aside designation. The University of Maryland, College Park is the prime contractor, and it is a child entity of the University System of...
This is a purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to the University of Maryland, College Park. The $5,347.15 firm fixed price contract provides for the fall tuition of 4 non-resident credits for Seong-in Hyun. This award does not have a set-aside designation. The University of Maryland, College Park is a state-controlled institution of higher learning that serves as a prime...

The University of Maryland, College Park is delivering services and products to the National Institutes of Health's National Institute on Drug Abuse under a one-year, $25,000 firm fixed price purchase order awarded by the Department of Health and Human Services. As the prime contractor, University of Maryland will perform the work at its Baltimore location under this contract associated with the NIH's efforts to address substance abuse and addiction issues. No subcontractors or set aside designations were indicated. The award provides funding for the University's support of NIH's research programs aimed at understanding drug abuse and developing effective prevention and treatment strategies.

Generated 12/22/23, 4:50 PM